Wockhardt sinks after US import alert at second site
This article was originally published in Scrip
Executive Summary
Shares of Wockhardt nosedived on Indian bourses after the US FDA placed its Chikalthana site under import alert following deviations in good manufacturing practices – the firm's second site to face such regulatory action this year